Equities

AstraZeneca PLC

AZN:LSE

AstraZeneca PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10,062.00
  • Today's Change93.00 / 0.93%
  • Shares traded5.44m
  • 1 Year change-1.28%
  • Beta0.3888
Data delayed at least 20 minutes, as of Nov 21 2024 16:58 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income6,8992,501(265)
Depreciation/depletion5,3875,4806,530
Non-Cash items657460127
Cash taxes paid, supplemental2,3661,6231,743
Cash interest paid, supplemental1,081849721
Changes in working capital(2598)1,367(429)
Total cash from operations10,3459,8085,963
INVESTING
Capital expenditures(3778)(2571)(2200)
Other investing and cash flow items, total(286)(389)(8858)
Total cash from investing(4064)(2960)(11058)
FINANCING
Financing cash flow items(886)(1047)(178)
Total cash dividends paid(4481)(4364)(3856)
Issuance (retirement) of stock, net332929
Issuance (retirement) of debt, net(1233)(1441)7,654
Total cash from financing(6567)(6823)3,649
NET CHANGE IN CASH
Foreign exchange effects(60)(80)(62)
Net change in cash(346)(55)(1508)
Net cash-begin balance/reserved for future use5,9836,0387,546
Net cash-end balance/reserved for future use5,6375,9836,038
SUPPLEMENTAL INCOME
Depreciation, supplemental5,3875,4806,530
Cash interest paid, supplemental1,081849721
Cash taxes paid, supplemental2,3661,6231,743
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.